HomeCMMB • NASDAQ
Chemomab Therapeutics Ltd - ADR
Follow
$3.14
7.92%
After Hours:(0.35%)+0.011
$3.15
Closed: Aug 29, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.26M | -39.97% |
Net income | -2.06M | 43.35% |
Net profit margin | — | — |
Earnings per share | -0.02 | -130.77% |
EBITDA | -2.25M | 40.19% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.37M | -26.42% |
Total assets | 11.13M | -23.48% |
Total liabilities | 1.43M | -68.63% |
Total equity | 9.70M | — |
Shares outstanding | 5.17M | — |
Price to book | 1.82 | — |
Return on assets | -47.23% | — |
Return on capital | -55.48% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.06M | 43.35% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$3.41
Day range
$3.10 - $3.43
Year range
$3.10 - $10.20
Market cap
16.58M USD
Avg Volume
71.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2011
Website
Employees
16
